Teaming up with the online retail giant marks a pivotal moment for Zoa in its support of the circular fashion economy. We are glad to share that this partnership has featured in multiple publications, including in Glamour, OK! and Grazia magazines.
The two principals have extensive legal and financial backgrounds - one practiced as a solicitor in private equity transactions and investment funds before becoming a partner and general counsel for an investment house. The other is a chartered accountant and management consultant by training, with many years experience consulting in a wide variety of industries.
Perlin Partners offer a business advisory service that draws on a combination of legal, business and financial expertise. They specialise in advising companies looking at raising funds, reorganising their corporate structures, facing regulatory issues, and managing a sale, merger or acquisition.
Perlin Partners help Adjuvo to execute members investments and undertake due diligence projects. They specifically advise on underlying corporate documents, areas for negotiation, corporate structures and other related issues.
CEO: Slava Kremerman
Adjuvo Investment: £21 million
Date of Most Recent Investment: March 2024
Zen Educate is a streamlined technology platform matching schools and supply teachers with a presence in both the UK and the US. Instead of using expensive and traditional agencies, schools can book supply teachers through Zen’s simple online platform.
By doing so, schools pay half the fees of a traditional agency and supply teachers get
paid up to 30% more for roles that are algorithmically better matched for both parties. All while cutting down on administrative hassle.
CEO: Pawel Kisielewski
Investment: £4 million including third party investment introduced by Adjuvo
Date of Most Recent Investment: August 2024
CCm Technologies have developed a fertiliser, produced from organic waste streams, that is not only regenerative to the soil, but removes greenhouse gases from the air, without sacrificing crop yield or affordability.
It is the only fertiliser that has been certified carbon negative by the Carbon Trust which is of vital importance to the many food and beverage companies who need to be able to verify and provide their supply chain’s carbon footprint data under Scope 3 emissions.
CEO: George Panton
Adjuvo Investment: £145k
Date of Most Recent Investment: February 2024
Boardforms offers board evaluation software to boards of directors.
"There should be a formal and rigorous annual evaluation of the performance of the board, its committees, the chair and individual directors" (UK Corporate Governance Code 2018).
The company refines the board evaluation process by producing an actionable report, leveraging AI.
CEO: Aaron Simpson
Adjuvo Investment: £6.8 million
Date of Most Recent Investment: December 2023
Kindred is transforming e-commerce transactions into a force for good, without changing the way that people shop online.
This is achieved via the company's patented technology that integrates with browsers and apps to provide end users with discount and cash-back offers.
CEO: Ean Brown
Adjuvo Investment: £1.7 million
Date of Most Recent Investment: April 2024
Skarper has developed world's first, click on, and click off, patented device that converts the majority of bicycles ever manufactured into premium quality electric bikes, and back again, in less than five minutes.
It’s designed to be effortlessly removable, allowing the consumer to choose if they would like an electric bike or a standard bicycle at any given moment.
CEO: Neil Barron
Adjuvo Investment: £1.7 million
Date of Most Recent Investment: July 2023
'The best bike lock on the planet'
In Sept 2022, LITELOK X launched a range of lightweight D-locks that are armoured with Barronium™: a new composite technology, which offers unparalleled resistance to angle grinders.
After having several bikes stolen on the streets of London, Founder and CEO, Neil, felt determined to ensure that customers stay one step ahead in safeguarding their prized possessions.
Founder: Tom Lipinski
Adjuvo Investment: £1.5 million
Date of Most Recent Investment: September 2023
A first of its kind, Q-Bot is a Robotics as a Service solution for underfloor insulation. With 36 patents granted globally, they have developed small remote-controlled robots that can go underneath floorboards with ease – precision spraying insulating foam to everywhere required and permitted.
Its technology is both award winning and fully accredited, having successfully insulated circa 3,500 homes to date. The company is the default market leader in a hitherto untapped market worth £140 billion.
CEO: Isabella West
Adjuvo Investment: £716k
Date of Most Recent Investment: June 2023
Zoa Rental provide white-label technology that powers pay-per-wear fashion for retailers. They remove the complications of rental by providing the technology, data, logistics, and operations behind this offering – all via a SaaS model.
The company has developed a ‘smart rental button’ that fully integrates rental into a brand’s existing website for the first time, enabling retailers to launch their own-brand rental service.
CEO: Tash Grossman
Adjuvo Investment: £1.1 million
Date of Most Recent Investment: May 2024
Slip is a retail technology company that recognises receipts as one of the most under-appreciated assets in the retail world.
The business is on a mission to re-engineer receipts from a proof of purchase, which signifies the end of a customer journey, to a tool that helps retailers to better understand, re-engage, and reward their customers after leaving the store.
Whilst most investors call themselves “value-add”, having taken investment from and worked with Adjuvo for the past year, I can truly say that they are the very definition of that statement. Adjuvo has members who are leaders of practically every industry, and provide access to opportunities that can truly accelerate any business they choose to invest in. I am proud and grateful to have them as shareholders.
Adjuvo Investment: £2.4 million
Date of Most Recent Investment: August 2023
The Curators are on a mission to build the UK’s leading functional savoury snacks brand for modern active consumers, creating products with bold flavour and big nutrition.
The company has developed an innovative range of premium snacks that are light, crunchy and packed full of protein, underpinned by a distinctive and striking lifestyle brand.
CEO: Hannah Chappatte
Adjuvo Investment: £1.6 million
Date of Most Recent Investment: November 2023
Hybr is a curated rental platform for first-time renters offering everything they need in one place, whilst ensuring landlords can fill vacancies quickly with pre-vetted young tenants.
The company has already supported over 25,000 students in their property search, has partnered with 20 UK universities, and has recently onboarded the likes of Touchstone and Greystar to its landlord portfolio.
CEO: Jenny Tsai
Adjuvo Investment: £2.3 million
Date of Most Recent Investment: March 2023
WeArisma’s data works to drive better choices and higher impact for every dollar spent on influencer marketing. The platform enables brands and their marketing agencies to forecast, measure, and optimize their influencer marketing performance and global competitive positioning.
The company has become of interest to financial services institutions, building ESG indicators to understand the social credit risk of influencer marketing.
CEO: Thom Groot
Adjuvo Investment: £500k
Date of Most Recent Investment: August 2022
The Electric Car Scheme makes it easier for people to adopt electric cars by cutting the cost by 30-60% and taking out the complexity of getting a car through salary sacrifice. It’s like the Cycle to Work scheme – only better!
You and your team can switch to drive any electric car through subscription or lease and include maintenance, charge point installation, and car insurance via the scheme.
CEO: Dr Ashton Barnett-Vanes
Adjuvo Investment: £800k
Date of Most Recent Investment: December 2023
Javelo is a clinician-led healthcare technology company based in Scotland.
The company develops patent-protected solutions to improve safety and comfort for patients receiving intravenous therapy or haemodialysis.
The company’s technology is informed by the needs of patients and clinicians, delivering products that are effective, affordable and sustainable.
CEO: Jonathan O’Halloran
Adjuvo Investment: £15 million
Date of Most Recent Investment: August 2022
QuantuMDx is a progressive MedTech company passionate about empowering the world to control disease and reduce suffering. The company solves real-world diagnostic problems by creating multiplex molecular solutions for the Point of Need.
Q-POC™ is a rapid, portable, sample to answer multiplex PCR device. It has been designed for use in a range of real-world settings, such as hospitals, clinics, pharmacies and dentists, providing accurate PCR results.
CEO: Steve Pomfret
Adjuvo Investment: £1.4 million
Date of Most Recent Investment: June 2023
Cygnetise is an authorised signatory management platform that allows customers to manage, share, and validate signatory data using blockchain technology. The company is on a mission to become the global standard for organisations, corporations and banks to maintain, record, and securely share their authorised signatory lists.
Cygnetise is not an e-signature application, but a real-time record management system for authorised signatories. The business already counts 59 customers, including the likes of Societe Generale, SoftBank, Investec, Stonehage Fleming and PwC.
CEO: Ivan Mazour
Adjuvo Investment: £4.5 million
Date of Most Recent Investment: November 2021
Ometria is a customer data and marketing platform that combines profile unification and predictive intelligence with cross-channel marketing. The company helps retailers increase customer loyalty and repeat purchases by sending personalised messages throughout the customer journey.
The company is trusted by global fast-growing retail brands, such as Sephora and Hotel Chocolat.
Thompson Taraz is a leading UK fund and investment services group incorporating third party fund management, depositary, administration, custodian, nominee and investment consulting services.
They have a twenty year track record and are currently involved in the management and/or administration of over 70 collective investment vehicles with hundreds of underlying investments and over 7,000 investors with a total gross asset value exceeding £2 billion. They currently have circa £1 billion under management, and a particular focus on venture capital, EIS, property, energy and debt investment structures.
Philip Hare & Associates LLP is a tax consultancy business which specialises in the Enterprise Investment Scheme (EIS), Seed EIS, Venture Capital Trusts (VCT) and Social Investment Tax Relief (SITR). They advise small and medium sized companies and their investors in respect of the tax relief available for investment, and the conditions that need to be met by both the company and the investor. They are in regular contact with specialists at HMRC discussing solutions to technical and administrative issues that arise from the schemes.
Whilst most investors call themselves “value-add”, having taken investment from and worked with Adjuvo for the past year, I can truly say that they are the very definition of that statement. Adjuvo has members who are leaders of practically every industry, and provide access to opportunities that can truly accelerate any business they choose to invest in. I am proud and grateful to have them as shareholders.
We have been supported by Adjuvo since 2016. They have introduced a wide range of leading investors, but have also built an active and valuable relationship with me and my team – in recent weeks they have been involved at the heart of our Covid-19 response.
There are a lot of angels introduced to us through Adjuvo who have a real understanding of how the marketing landscape is shifting. You really need those innovators who have made it a really great experience. The team have been tremendous in doing due diligence, talking to our clients, understanding why they value us, and then communicating that to the investors. It’s been fascinating and I’ve learned so much.